The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial (Q46755588)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

0 references

1 reference

based on heuristic

inferred from title

author name string

Joel M Neutel

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

Elijah Saunders

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

George L Bakris

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

William C Cushman

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

Keith C Ferdinand

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

Elizabeth O Ofili

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

James R Sowers

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

Michael A Weber

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

INCLUSIVE Investigators

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

publication date

1 October 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

578-586

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Global burden of hypertension: analysis of worldwide data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Successful blood pressure control in the African American Study of Kidney Disease and Hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Safety and tolerability of eprosartan in combination with hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Telmisartan/hydrochlorothiazide: a new fixed dose combination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Why is hypertension so frequently uncontrolled in secondary prevention?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Metabolic manifestations of low-dose diuretics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.04720.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2004.04720.X

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

release_6ipv43fppngbjjc5rlotjwpv2y

1 reference

https://api.fatcat.wiki/v0/release/6ipv43fppngbjjc5rlotjwpv2y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/6ipv43fppngbjjc5rlotjwpv2y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16227760

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46755588&oldid=2129915056"